Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
TNF-Related Apoptosis-Inducing Ligand | 28 | 2024 | 192 | 6.410 |
Why?
|
Glioblastoma | 44 | 2024 | 3482 | 6.150 |
Why?
|
Brain Neoplasms | 48 | 2024 | 9031 | 4.460 |
Why?
|
Oncolytic Virotherapy | 17 | 2023 | 516 | 3.920 |
Why?
|
Mesenchymal Stem Cells | 18 | 2024 | 1642 | 3.210 |
Why?
|
Stem Cell Transplantation | 17 | 2016 | 1600 | 2.600 |
Why?
|
Stem Cells | 22 | 2023 | 3522 | 2.540 |
Why?
|
Simplexvirus | 11 | 2023 | 803 | 1.710 |
Why?
|
Glioma | 19 | 2020 | 3455 | 1.710 |
Why?
|
Oncolytic Viruses | 8 | 2023 | 344 | 1.650 |
Why?
|
Mesenchymal Stem Cell Transplantation | 8 | 2022 | 499 | 1.560 |
Why?
|
Thrombospondin 1 | 3 | 2024 | 257 | 1.550 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 7 | 2021 | 58 | 1.390 |
Why?
|
Tumor Microenvironment | 11 | 2024 | 3877 | 1.360 |
Why?
|
Apoptosis | 25 | 2024 | 9486 | 1.310 |
Why?
|
Cell Line, Tumor | 47 | 2024 | 16981 | 1.310 |
Why?
|
Interferon-beta | 2 | 2024 | 345 | 1.300 |
Why?
|
Exotoxins | 2 | 2021 | 121 | 1.220 |
Why?
|
Neoplasms | 19 | 2024 | 22170 | 1.100 |
Why?
|
Immunotherapy | 14 | 2023 | 4652 | 1.080 |
Why?
|
Genes, Transgenic, Suicide | 2 | 2023 | 34 | 1.060 |
Why?
|
Interleukin-13 | 2 | 2021 | 392 | 1.050 |
Why?
|
Genetic Engineering | 8 | 2018 | 933 | 1.040 |
Why?
|
Xenograft Model Antitumor Assays | 18 | 2020 | 3602 | 1.020 |
Why?
|
Neural Stem Cells | 4 | 2018 | 888 | 0.960 |
Why?
|
Mice | 70 | 2024 | 81525 | 0.940 |
Why?
|
Single-Chain Antibodies | 2 | 2024 | 111 | 0.920 |
Why?
|
Neoplastic Stem Cells | 6 | 2024 | 1347 | 0.890 |
Why?
|
Molecular Targeted Therapy | 7 | 2019 | 2811 | 0.870 |
Why?
|
Animals | 91 | 2024 | 168459 | 0.860 |
Why?
|
Pseudomonas | 2 | 2021 | 124 | 0.850 |
Why?
|
Herpesvirus 1, Human | 6 | 2023 | 753 | 0.820 |
Why?
|
Mice, Nude | 21 | 2018 | 3615 | 0.820 |
Why?
|
Genetic Vectors | 16 | 2015 | 3395 | 0.810 |
Why?
|
Interleukin-13 Receptor alpha2 Subunit | 1 | 2021 | 8 | 0.770 |
Why?
|
Drug Resistance, Neoplasm | 12 | 2024 | 5305 | 0.740 |
Why?
|
Immunotherapy, Adoptive | 4 | 2023 | 1469 | 0.680 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2023 | 5671 | 0.670 |
Why?
|
Hyaluronoglucosaminidase | 2 | 2020 | 136 | 0.650 |
Why?
|
Cell Movement | 9 | 2020 | 5203 | 0.640 |
Why?
|
Cell Death | 6 | 2023 | 1678 | 0.610 |
Why?
|
Lentivirus | 7 | 2014 | 508 | 0.600 |
Why?
|
Antibodies, Bispecific | 2 | 2017 | 196 | 0.580 |
Why?
|
Gene Expression Regulation, Neoplastic | 11 | 2021 | 8547 | 0.570 |
Why?
|
Neoplasms, Experimental | 2 | 2020 | 1229 | 0.570 |
Why?
|
Tissue Engineering | 3 | 2019 | 1868 | 0.560 |
Why?
|
Protein Interaction Domains and Motifs | 2 | 2020 | 452 | 0.550 |
Why?
|
Luminescent Measurements | 6 | 2014 | 342 | 0.550 |
Why?
|
Drug Delivery Systems | 4 | 2016 | 2226 | 0.520 |
Why?
|
Antineoplastic Agents | 13 | 2022 | 13639 | 0.510 |
Why?
|
MicroRNAs | 3 | 2020 | 3816 | 0.510 |
Why?
|
Up-Regulation | 4 | 2020 | 4124 | 0.510 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10194 | 0.510 |
Why?
|
Bacterial Toxins | 1 | 2021 | 931 | 0.500 |
Why?
|
Peptide Elongation Factor 2 | 1 | 2015 | 17 | 0.500 |
Why?
|
Recombinant Fusion Proteins | 4 | 2016 | 3734 | 0.490 |
Why?
|
Neurons | 11 | 2020 | 9463 | 0.490 |
Why?
|
Cancer Vaccines | 1 | 2023 | 1051 | 0.490 |
Why?
|
Humans | 109 | 2024 | 761504 | 0.480 |
Why?
|
Disease Models, Animal | 15 | 2024 | 18252 | 0.480 |
Why?
|
Adenoviridae | 4 | 2020 | 1084 | 0.470 |
Why?
|
Membrane Glycoproteins | 5 | 2005 | 3702 | 0.470 |
Why?
|
Hyaluronic Acid | 3 | 2020 | 483 | 0.460 |
Why?
|
Melanoma, Experimental | 1 | 2017 | 560 | 0.450 |
Why?
|
Down-Regulation | 2 | 2020 | 2919 | 0.450 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2005 | 4352 | 0.450 |
Why?
|
Quinazolinones | 2 | 2019 | 221 | 0.440 |
Why?
|
Luminescent Proteins | 6 | 2012 | 837 | 0.420 |
Why?
|
Microscopy, Fluorescence | 5 | 2012 | 2645 | 0.410 |
Why?
|
Interleukins | 3 | 2012 | 782 | 0.400 |
Why?
|
Triazines | 1 | 2014 | 311 | 0.400 |
Why?
|
Brain | 9 | 2024 | 27112 | 0.390 |
Why?
|
Neovascularization, Pathologic | 3 | 2024 | 2645 | 0.390 |
Why?
|
Optical Phenomena | 1 | 2012 | 106 | 0.390 |
Why?
|
Neoplasm Metastasis | 4 | 2018 | 4915 | 0.390 |
Why?
|
Cell Survival | 9 | 2020 | 5791 | 0.380 |
Why?
|
Genes, Reporter | 5 | 2020 | 1529 | 0.380 |
Why?
|
Transduction, Genetic | 5 | 2014 | 903 | 0.370 |
Why?
|
Medulloblastoma | 2 | 2014 | 678 | 0.360 |
Why?
|
Morpholines | 1 | 2014 | 581 | 0.360 |
Why?
|
Receptors, Death Domain | 2 | 2021 | 31 | 0.350 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2014 | 571 | 0.340 |
Why?
|
Ganciclovir | 3 | 2023 | 252 | 0.330 |
Why?
|
Furans | 1 | 2010 | 202 | 0.330 |
Why?
|
Caspases | 4 | 2018 | 879 | 0.320 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3617 | 0.320 |
Why?
|
Viral Proteins | 2 | 2014 | 1804 | 0.320 |
Why?
|
Apoptosis Regulatory Proteins | 6 | 2020 | 1135 | 0.320 |
Why?
|
Cell Proliferation | 9 | 2023 | 10445 | 0.320 |
Why?
|
Drug Resistance | 1 | 2015 | 1596 | 0.320 |
Why?
|
Cell Adhesion Molecules | 5 | 2014 | 1600 | 0.310 |
Why?
|
Signal Transduction | 13 | 2020 | 23445 | 0.300 |
Why?
|
Cerebellar Neoplasms | 1 | 2012 | 586 | 0.290 |
Why?
|
Antibodies | 1 | 2015 | 2418 | 0.290 |
Why?
|
Tumor Cells, Cultured | 7 | 2019 | 6132 | 0.280 |
Why?
|
Dacarbazine | 2 | 2017 | 559 | 0.280 |
Why?
|
Hydrogels | 1 | 2013 | 720 | 0.280 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11742 | 0.280 |
Why?
|
Thymidine Kinase | 3 | 2023 | 286 | 0.280 |
Why?
|
Immunomodulation | 2 | 2021 | 549 | 0.270 |
Why?
|
Tumor Burden | 4 | 2017 | 1893 | 0.270 |
Why?
|
Diagnostic Imaging | 4 | 2011 | 3530 | 0.270 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2822 | 0.260 |
Why?
|
Premedication | 1 | 2007 | 246 | 0.260 |
Why?
|
Drug Utilization Review | 1 | 2007 | 248 | 0.250 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2014 | 2057 | 0.250 |
Why?
|
Breast Neoplasms | 6 | 2023 | 21012 | 0.250 |
Why?
|
Melanoma | 2 | 2023 | 5709 | 0.250 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2020 | 718 | 0.240 |
Why?
|
Oligonucleotides, Antisense | 1 | 2007 | 461 | 0.240 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1971 | 0.240 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2008 | 617 | 0.240 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5315 | 0.240 |
Why?
|
Embryonic Stem Cells | 2 | 2009 | 1263 | 0.230 |
Why?
|
Bystander Effect | 2 | 2018 | 90 | 0.230 |
Why?
|
HIV Protease | 1 | 2004 | 97 | 0.220 |
Why?
|
Pyridines | 3 | 2021 | 2875 | 0.220 |
Why?
|
Green Fluorescent Proteins | 4 | 2012 | 2065 | 0.220 |
Why?
|
Killer Cells, Natural | 2 | 2023 | 2200 | 0.220 |
Why?
|
Vesicular Stomatitis | 1 | 2023 | 18 | 0.210 |
Why?
|
Ligands | 2 | 2021 | 3272 | 0.210 |
Why?
|
Transfection | 5 | 2014 | 5774 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2021 | 1405 | 0.210 |
Why?
|
Polycythemia Vera | 1 | 2004 | 161 | 0.200 |
Why?
|
RNA Interference | 2 | 2007 | 2831 | 0.200 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2007 | 464 | 0.200 |
Why?
|
Caspase 3 | 3 | 2011 | 731 | 0.200 |
Why?
|
Mice, SCID | 3 | 2014 | 2626 | 0.190 |
Why?
|
Neoplasm Transplantation | 4 | 2020 | 2016 | 0.190 |
Why?
|
YY1 Transcription Factor | 1 | 2021 | 60 | 0.190 |
Why?
|
Bacterial Proteins | 1 | 2015 | 3847 | 0.190 |
Why?
|
Bioengineering | 1 | 2022 | 99 | 0.180 |
Why?
|
Molecular Imaging | 3 | 2018 | 815 | 0.180 |
Why?
|
Immunotoxins | 1 | 2021 | 175 | 0.180 |
Why?
|
Luciferases | 5 | 2005 | 714 | 0.180 |
Why?
|
Threonine | 1 | 2001 | 271 | 0.180 |
Why?
|
Tumor Suppressor Proteins | 2 | 2021 | 2803 | 0.180 |
Why?
|
Cell Transplantation | 3 | 2011 | 472 | 0.180 |
Why?
|
Enzyme Inhibitors | 2 | 2010 | 3712 | 0.180 |
Why?
|
Cell Differentiation | 4 | 2020 | 11528 | 0.180 |
Why?
|
Combined Modality Therapy | 4 | 2015 | 8529 | 0.170 |
Why?
|
RNA, Small Interfering | 3 | 2010 | 3429 | 0.170 |
Why?
|
Caspase 7 | 2 | 2011 | 50 | 0.170 |
Why?
|
HT29 Cells | 2 | 2017 | 193 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2024 | 9280 | 0.170 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 891 | 0.170 |
Why?
|
Half-Life | 1 | 2020 | 651 | 0.160 |
Why?
|
Serpins | 1 | 2020 | 247 | 0.160 |
Why?
|
Drug Carriers | 2 | 2014 | 706 | 0.160 |
Why?
|
bcl-2-Associated X Protein | 1 | 2020 | 282 | 0.160 |
Why?
|
Nanostructures | 1 | 2024 | 553 | 0.160 |
Why?
|
Gene Transfer Techniques | 1 | 2004 | 1206 | 0.160 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13380 | 0.160 |
Why?
|
Leg | 1 | 2004 | 1088 | 0.160 |
Why?
|
Angiogenesis Inhibitors | 2 | 2024 | 2047 | 0.160 |
Why?
|
Extracellular Matrix | 3 | 2020 | 1726 | 0.160 |
Why?
|
Immunization | 1 | 2023 | 1228 | 0.150 |
Why?
|
Pyrimidines | 1 | 2010 | 3028 | 0.150 |
Why?
|
Survival Analysis | 3 | 2020 | 10090 | 0.150 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2021 | 455 | 0.150 |
Why?
|
Cell Growth Processes | 2 | 2010 | 384 | 0.150 |
Why?
|
Adult Stem Cells | 1 | 2020 | 221 | 0.150 |
Why?
|
Arabidopsis | 1 | 2001 | 465 | 0.150 |
Why?
|
HEK293 Cells | 4 | 2017 | 4278 | 0.150 |
Why?
|
HMGB Proteins | 1 | 2017 | 45 | 0.150 |
Why?
|
Preoperative Care | 1 | 2007 | 2242 | 0.150 |
Why?
|
Receptors, Somatostatin | 1 | 2018 | 136 | 0.140 |
Why?
|
Pulmonary Fibrosis | 1 | 2021 | 505 | 0.140 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2020 | 1351 | 0.140 |
Why?
|
Blotting, Western | 3 | 2012 | 5035 | 0.140 |
Why?
|
Gene Knockdown Techniques | 4 | 2014 | 1612 | 0.140 |
Why?
|
Cell Line | 4 | 2017 | 15601 | 0.140 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2017 | 100 | 0.130 |
Why?
|
Coculture Techniques | 2 | 2010 | 1341 | 0.130 |
Why?
|
Prodrugs | 1 | 2018 | 261 | 0.130 |
Why?
|
Vero Cells | 3 | 2014 | 482 | 0.130 |
Why?
|
HCT116 Cells | 1 | 2017 | 404 | 0.130 |
Why?
|
Virus Replication | 4 | 2023 | 2435 | 0.130 |
Why?
|
Treatment Outcome | 10 | 2022 | 64680 | 0.130 |
Why?
|
Hematopoietic Stem Cells | 1 | 2008 | 3396 | 0.130 |
Why?
|
Immunophenotyping | 1 | 2020 | 1870 | 0.130 |
Why?
|
Fluorescent Dyes | 3 | 2013 | 1903 | 0.130 |
Why?
|
Fluorescence | 2 | 2009 | 756 | 0.120 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2017 | 662 | 0.120 |
Why?
|
Retinoid X Receptors | 1 | 2014 | 91 | 0.120 |
Why?
|
Cell Count | 2 | 2011 | 1835 | 0.120 |
Why?
|
Oncogene Proteins v-erbB | 1 | 2014 | 17 | 0.120 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1092 | 0.120 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2014 | 33 | 0.120 |
Why?
|
Nervous System Diseases | 1 | 2005 | 1666 | 0.120 |
Why?
|
Protein Kinases | 1 | 2001 | 1608 | 0.120 |
Why?
|
Receptor, Notch1 | 1 | 2017 | 496 | 0.120 |
Why?
|
Retinoids | 1 | 2014 | 99 | 0.110 |
Why?
|
Positron-Emission Tomography | 4 | 2018 | 6485 | 0.110 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2012 | 2298 | 0.110 |
Why?
|
Injections, Intralesional | 1 | 2014 | 280 | 0.110 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 382 | 0.110 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2057 | 0.110 |
Why?
|
Genomic Instability | 1 | 2017 | 709 | 0.110 |
Why?
|
Ki-67 Antigen | 2 | 2012 | 629 | 0.110 |
Why?
|
Biomimetic Materials | 1 | 2014 | 172 | 0.110 |
Why?
|
Protein Engineering | 1 | 2016 | 549 | 0.100 |
Why?
|
Capsules | 1 | 2013 | 191 | 0.100 |
Why?
|
Dependovirus | 2 | 2008 | 718 | 0.100 |
Why?
|
Benzamides | 2 | 2021 | 1370 | 0.100 |
Why?
|
Liver Neoplasms | 4 | 2014 | 4320 | 0.100 |
Why?
|
Interferon-gamma | 1 | 2020 | 3162 | 0.100 |
Why?
|
Mutation | 3 | 2021 | 30052 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8002 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2020 | 2303 | 0.090 |
Why?
|
Time Factors | 7 | 2012 | 39967 | 0.090 |
Why?
|
Membrane Proteins | 6 | 2020 | 7856 | 0.090 |
Why?
|
Bacteria | 1 | 2022 | 2199 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20098 | 0.090 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 670 | 0.090 |
Why?
|
DNA Damage | 1 | 2020 | 2446 | 0.090 |
Why?
|
Drug Synergism | 1 | 2014 | 1755 | 0.080 |
Why?
|
Neoplasm Invasiveness | 3 | 2012 | 3595 | 0.080 |
Why?
|
Endothelial Cells | 2 | 2014 | 3548 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2022 | 3065 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2898 | 0.080 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1896 | 0.080 |
Why?
|
Luciferases, Renilla | 1 | 2009 | 21 | 0.080 |
Why?
|
Meningeal Neoplasms | 1 | 2018 | 1248 | 0.080 |
Why?
|
Luciferases, Firefly | 1 | 2009 | 37 | 0.080 |
Why?
|
Immunohistochemistry | 3 | 2024 | 11076 | 0.080 |
Why?
|
Cytokines | 2 | 2022 | 7396 | 0.080 |
Why?
|
Spectroscopy, Near-Infrared | 2 | 2004 | 740 | 0.080 |
Why?
|
Methods | 1 | 2009 | 1067 | 0.080 |
Why?
|
Cisplatin | 1 | 2015 | 1651 | 0.080 |
Why?
|
Cells, Cultured | 4 | 2020 | 18965 | 0.080 |
Why?
|
Transplantation, Heterologous | 3 | 2013 | 2385 | 0.080 |
Why?
|
Fluorouracil | 2 | 2012 | 1641 | 0.080 |
Why?
|
MAP Kinase Signaling System | 2 | 2012 | 1486 | 0.070 |
Why?
|
Models, Molecular | 2 | 2012 | 5439 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2014 | 946 | 0.070 |
Why?
|
Tomography, Optical | 1 | 2008 | 129 | 0.070 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2012 | 774 | 0.070 |
Why?
|
Female | 14 | 2023 | 392644 | 0.070 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 22169 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3802 | 0.070 |
Why?
|
Pandemics | 3 | 2022 | 8654 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3080 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 9000 | 0.070 |
Why?
|
Protein Binding | 2 | 2020 | 9351 | 0.070 |
Why?
|
Transcription Factors | 3 | 2017 | 12128 | 0.070 |
Why?
|
Survival Rate | 1 | 2020 | 12725 | 0.070 |
Why?
|
Dendritic Cells | 1 | 2017 | 2747 | 0.070 |
Why?
|
Craniotomy | 1 | 2011 | 741 | 0.070 |
Why?
|
Pakistan | 1 | 2007 | 292 | 0.060 |
Why?
|
Lung | 2 | 2022 | 10000 | 0.060 |
Why?
|
RNA-Binding Proteins | 5 | 2014 | 1897 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2009 | 646 | 0.060 |
Why?
|
Medical Audit | 1 | 2007 | 453 | 0.060 |
Why?
|
Galactosides | 1 | 2005 | 54 | 0.060 |
Why?
|
Midazolam | 1 | 2007 | 266 | 0.060 |
Why?
|
Gene Expression | 2 | 2014 | 7581 | 0.060 |
Why?
|
Hospitals, University | 1 | 2007 | 563 | 0.060 |
Why?
|
Nervous System Neoplasms | 1 | 2005 | 91 | 0.060 |
Why?
|
Immunoconjugates | 1 | 2012 | 954 | 0.060 |
Why?
|
Molecular Probe Techniques | 1 | 2005 | 111 | 0.060 |
Why?
|
Regenerative Medicine | 1 | 2008 | 306 | 0.060 |
Why?
|
Biocompatible Materials | 1 | 2013 | 1685 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6228 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2017 | 4580 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2014 | 9539 | 0.050 |
Why?
|
Caspase 1 | 1 | 2004 | 225 | 0.050 |
Why?
|
Vesicular stomatitis Indiana virus | 1 | 2023 | 93 | 0.050 |
Why?
|
beta-Galactosidase | 1 | 2004 | 574 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2825 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 2007 | 443 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
Argininosuccinate Synthase | 1 | 2022 | 16 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
Polyethylene Glycols | 2 | 2022 | 1189 | 0.050 |
Why?
|
Cell Cycle | 1 | 2010 | 2932 | 0.050 |
Why?
|
Formaldehyde | 1 | 2024 | 358 | 0.050 |
Why?
|
Tomography, Emission-Computed | 1 | 2005 | 1122 | 0.050 |
Why?
|
Computer Systems | 1 | 2003 | 470 | 0.050 |
Why?
|
HIV Protease Inhibitors | 1 | 2004 | 432 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2005 | 754 | 0.050 |
Why?
|
Hydrolases | 1 | 2022 | 147 | 0.050 |
Why?
|
Models, Biological | 2 | 2020 | 9469 | 0.050 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2012 | 2790 | 0.050 |
Why?
|
Mutagenesis | 1 | 2005 | 1232 | 0.050 |
Why?
|
Benzodiazepines | 1 | 2007 | 1132 | 0.040 |
Why?
|
Disease Progression | 2 | 2020 | 13506 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2004 | 485 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5368 | 0.040 |
Why?
|
Endopeptidases | 1 | 2004 | 774 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 1068 | 0.040 |
Why?
|
Arabidopsis Proteins | 1 | 2001 | 264 | 0.040 |
Why?
|
Adult | 3 | 2024 | 221177 | 0.040 |
Why?
|
bcl-X Protein | 1 | 2021 | 410 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2005 | 4174 | 0.040 |
Why?
|
Granzymes | 1 | 2020 | 277 | 0.040 |
Why?
|
Bioreactors | 1 | 2020 | 247 | 0.040 |
Why?
|
Forecasting | 1 | 2008 | 2928 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2020 | 341 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9177 | 0.040 |
Why?
|
Electrophysiological Phenomena | 1 | 2020 | 307 | 0.040 |
Why?
|
Arginine | 1 | 2022 | 934 | 0.040 |
Why?
|
Endoplasmic Reticulum | 1 | 2004 | 1134 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3810 | 0.040 |
Why?
|
Genetic Markers | 1 | 2004 | 2601 | 0.040 |
Why?
|
Kinetics | 2 | 2004 | 6374 | 0.040 |
Why?
|
Octreotide | 1 | 2018 | 153 | 0.040 |
Why?
|
Epitopes | 1 | 2024 | 2503 | 0.040 |
Why?
|
Phosphorylation | 2 | 2014 | 8320 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 2748 | 0.040 |
Why?
|
Janus Kinase 2 | 1 | 2020 | 560 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2007 | 5869 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2022 | 1022 | 0.030 |
Why?
|
Indoles | 1 | 2005 | 1833 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 706 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2008 | 10766 | 0.030 |
Why?
|
Injections | 2 | 2013 | 830 | 0.030 |
Why?
|
Radiopharmaceuticals | 2 | 2018 | 2651 | 0.030 |
Why?
|
Zebrafish | 2 | 2017 | 3007 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1827 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2001 | 3597 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 733 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1330 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2005 | 6534 | 0.030 |
Why?
|
Melanoma, Amelanotic | 1 | 2014 | 19 | 0.030 |
Why?
|
Immunity | 1 | 2020 | 996 | 0.030 |
Why?
|
Doxorubicin | 2 | 2012 | 2224 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2872 | 0.030 |
Why?
|
Xenopus Proteins | 1 | 2017 | 434 | 0.030 |
Why?
|
Mice, Inbred CBA | 1 | 2014 | 436 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1784 | 0.030 |
Why?
|
Microglia | 1 | 2022 | 1361 | 0.030 |
Why?
|
Diethylnitrosamine | 1 | 2012 | 45 | 0.030 |
Why?
|
Factor XII | 1 | 2012 | 19 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2665 | 0.030 |
Why?
|
Polyribosomes | 1 | 2012 | 109 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2017 | 1561 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2416 | 0.030 |
Why?
|
NF-kappa B | 1 | 2021 | 2490 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2009 | 9606 | 0.020 |
Why?
|
Tretinoin | 1 | 2014 | 519 | 0.020 |
Why?
|
Cell Lineage | 1 | 2020 | 2555 | 0.020 |
Why?
|
Diffusion | 1 | 2013 | 814 | 0.020 |
Why?
|
Male | 5 | 2020 | 360804 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2004 | 3049 | 0.020 |
Why?
|
Base Sequence | 1 | 2001 | 12441 | 0.020 |
Why?
|
Feathers | 1 | 2009 | 29 | 0.020 |
Why?
|
Dihydrouracil Dehydrogenase (NADP) | 1 | 2009 | 17 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 13446 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2023 | 4936 | 0.020 |
Why?
|
Thymidylate Synthase | 1 | 2009 | 74 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2014 | 736 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2013 | 2265 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 17635 | 0.020 |
Why?
|
Integrins | 1 | 2013 | 834 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2010 | 459 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 3029 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2010 | 632 | 0.020 |
Why?
|
Risk Assessment | 1 | 2008 | 23995 | 0.020 |
Why?
|
Fatty Liver | 1 | 2012 | 790 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2012 | 12795 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 1 | 2008 | 685 | 0.020 |
Why?
|
Hepatocytes | 1 | 2012 | 1233 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6216 | 0.020 |
Why?
|
Fatty Acids | 1 | 2012 | 1808 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3778 | 0.010 |
Why?
|
Lac Operon | 1 | 2004 | 237 | 0.010 |
Why?
|
Injections, Intraventricular | 1 | 2004 | 225 | 0.010 |
Why?
|
Gene Transfer, Horizontal | 1 | 2004 | 145 | 0.010 |
Why?
|
Radiation, Ionizing | 1 | 2004 | 251 | 0.010 |
Why?
|
Staurosporine | 1 | 2004 | 242 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5789 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2538 | 0.010 |
Why?
|
Rats | 2 | 2010 | 23742 | 0.010 |
Why?
|
Glycoproteins | 1 | 2008 | 2203 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2009 | 5247 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 36426 | 0.010 |
Why?
|
Antigens, CD | 1 | 2008 | 4003 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2003 | 1420 | 0.010 |
Why?
|
Liver | 1 | 2012 | 7529 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9420 | 0.010 |
Why?
|
Peptides | 1 | 2008 | 4358 | 0.010 |
Why?
|
DNA | 1 | 2009 | 7212 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41487 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20570 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2004 | 14666 | 0.000 |
Why?
|
Aged | 1 | 2020 | 169289 | 0.000 |
Why?
|
Middle Aged | 1 | 2020 | 220895 | 0.000 |
Why?
|